Health Secretary Robert F. Kennedy Jr. has announced initiatives aimed at reducing the overprescription of selective serotonin reuptake inhibitors (SSRIs) in the U.S., promoting nonpharmaceutical interventions and enhancing support for patients seeking to discontinue these psychiatric medications, amidst ongoing debates about their accessibility and the nuances of withdrawal symptoms. #MentalHealth #PsychiatricMedication #Deprescribing #US #GB #DE
www.nytimes.com
Kennedy Starts a Push to Help Americans Quit Antidepressants
